The 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke includes key advances in stroke treatment, such as expanded eligibility for clot-removal procedures, new evidence ...

When someone is affected by a stroke, the standard treatment to restore blood flow to the brain can both save their life and ...

Currently in phase 2 trials, BB-031 is the first new mechanistic approach to ischemic stroke treatment in nearly 30 years.

Gaps in the U.S. stroke transfer system are drastically reducing survivors' chances of receiving critical treatment and ...

The approval of this accelerated pathway not only demonstrates the FDA’s full recognition of the quality, safety, and efficacy of the Phase 1 clinical data of hNPC01 in China, but also will ...

New nanomaterial passes the blood-brain barrier to reduce damaging inflammation after the most common form of stroke. When ...

A study led by scientists at the Centro Nacional de Investigaciones Carlos III (CNIC) demonstrates that stroke severity ...

Strokes are a medical emergency, yet imaging can capture only snapshots of how brain damage develops in the hours and days ...

A stroke patient at HonorHealth Research Institute is the first in Arizona to receive a new investigational treatment that ...

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...